196 related articles for article (PubMed ID: 30293336)
21. Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.
Tan CY; Arumugam T; Razali SNO; Yahya MA; Goh KJ; Shahrizaila N
J Clin Neurosci; 2018 Nov; 57():198-201. PubMed ID: 30145079
[TBL] [Abstract][Full Text] [Related]
22. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile.
Cea G; Idiáquez JF; Salinas R; Matamala JM; Villagra R; Stuardo A
J Clin Neurosci; 2020 Apr; 74():271-273. PubMed ID: 32067826
[TBL] [Abstract][Full Text] [Related]
24. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
25. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
[TBL] [Abstract][Full Text] [Related]
26. [A case of CIDP with diabetes mellitus who had good response to intravenous immune globulin].
Nakano M; Takase Y; Tatsumi C; Miura A; Matsuyama T; Kadekawa J; Yoshikawa H
Rinsho Shinkeigaku; 2002 Jan; 42(1):32-4. PubMed ID: 12355849
[TBL] [Abstract][Full Text] [Related]
27. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy.
Kim SW; Choi YC; Kim SM; Shin HY
Muscle Nerve; 2018 Sep; 58(3):407-412. PubMed ID: 29896772
[TBL] [Abstract][Full Text] [Related]
29. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
Allen JA; Bril V
Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584
[TBL] [Abstract][Full Text] [Related]
30. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
31. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy.
Hu N; Niu J; Liu M
Neurol Sci; 2022 Oct; 43(10):5885-5898. PubMed ID: 35737187
[TBL] [Abstract][Full Text] [Related]
32. Chronic inflammatory demyelinating polyneuropathy and diabetes.
Boulton AJ
Curr Diab Rep; 2003 Dec; 3(6):437-8. PubMed ID: 14611737
[No Abstract] [Full Text] [Related]
33. Biomarkers of CIDP in patients with diabetes or CMT1.
Latov N
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
[TBL] [Abstract][Full Text] [Related]
34. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
[TBL] [Abstract][Full Text] [Related]
35. Chronic inflammatory demyelinating polyradiculoneuropathy and anesthesia: a case series.
Mortenson AR; Sprung J; Watson JC; Dyck PJB; Weingarten TN
Acta Neurol Belg; 2017 Dec; 117(4):895-901. PubMed ID: 28936613
[TBL] [Abstract][Full Text] [Related]
36. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus.
Julio PR; Cortês MMM; Costallat LTL; Gaino JZ; França MC; Appenzeller S
Semin Arthritis Rheum; 2021 Feb; 51(1):158-165. PubMed ID: 33383292
[TBL] [Abstract][Full Text] [Related]
37. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.
Viala K; Maisonobe T; Stojkovic T; Koutlidis R; Ayrignac X; Musset L; Fournier E; Léger JM; Bouche P
J Peripher Nerv Syst; 2010 Mar; 15(1):50-6. PubMed ID: 20433605
[TBL] [Abstract][Full Text] [Related]
38. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review.
Rzepiński Ł; Doneddu PE; Cutellè C; Zawadka-Kunikowska M; Nobile-Orazio E
Neurol Sci; 2023 Sep; 44(9):3071-3082. PubMed ID: 37083958
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands.
Broers MC; de Wilde M; Lingsma HF; van der Lei J; Verhamme KMC; Jacobs BC
J Peripher Nerv Syst; 2022 Sep; 27(3):182-188. PubMed ID: 35567759
[TBL] [Abstract][Full Text] [Related]
40. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy.
Wilson JR; Park Y; Fisher MA
Electromyogr Clin Neurophysiol; 2000; 40(3):181-5. PubMed ID: 10812541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
